news aktuell GmbH

The high-performance single-seater 777 hypercar is born in Monza

Share
777 Hypercar prototype/Credits 777 Hypercar
777 Hypercar prototype/Credits 777 Hypercar

(Monza, Italy): – The 777 hypercar is a new Italian hypercar born of the excellent partnership with Andrea Levy, Dallara, and Gibson, built from technology used in motorsports and all informations and images are on www.777hypercar.com.

777 hypercar is built by 777 Motors, the car manufacturer based in the Autodromo Nazionale Monza and founded by Andrea Levy, an entrepreneur, car collector, racing driver, and president of MIMO Milano Monza Motorshow. The 777 hypercar project will be presented on November 22, limited to just 7 units, each of which will cost 7 million euros.

777 hypercar is at the top for performance thanks to an FIA-homologated carbon monocoque developed by Dallara, which generate an incredible downforce of 2,100 kg at a speed of 370 km/h, an extremely low weight of 900 kg, and a lateral acceleration from 3.5 to 4 g that keeps the car glued to the asphalt, giving an incredible estimate lap time of just 1 minute and 33 seconds in the Monza Circuit. The engine is a naturally aspirated V8, 4,500 cc of displacement, which develops 730 hp at 9,000 rpm, powered by synthetic fuels.

Along with the 777 hypercar, owners will also receive custom attire and machinery, tailored to their liking. An advanced machine is created for ad hoc to reinforce the neck area.

Data sheet 777 hypercar engineered by Dallara:

Headquarters: Autodromo Nazionale di Monza, the Temple of Speed

Chassis: FIA-homologated carbon monocoque

Engine: 8 V-cylinders

Displacement: 4,500 cc

Power: 730 hp at 9,000 rpm

Top speed: 370 km / h.

Weight: 900 kg

Lateral acceleration: 3.5 / 4.0 g.

Downforce: 2,100 kg at 370 km / h

Monza lap time: 1m33s

Limited edition of seven units

Price: 7 million euros

Delivery: from 2025

Contacts

Images

777 Hypercar prototype/Credits 777 Hypercar
777 Hypercar prototype/Credits 777 Hypercar
Download

About news aktuell GmbH

news aktuell GmbH
news aktuell GmbH
Mittelweg 144
20148 Hamburg

+49 (0)40 4113-32589http://www.newsaktuell.de

As wholly owned subsidiary of dpa, news aktuell provides business and organizations with effective access to media and consumers. Via the smart tools ots and zimpel, PR content accesses all media formats, including classical print, high click-rate online portals and social networks. In addition, news aktuell publishes all its customers’ PR content on www.presseportal.de, one of the PR portals with the greatest reach in Germany. By this means, all the relevant multipliers are reached globally, from editors, via digital influencers right up to specialist bloggers and interested consumers. news aktuell has been on the market since 1989. The company, with a staff complement of more than 135, has its headquarters in Hamburg. Other offices are in Berlin, Dusseldorf, Frankfurt und Munich.

Subscribe to releases from news aktuell GmbH

Subscribe to all the latest releases from news aktuell GmbH by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from news aktuell GmbH

R-Biopharm AG: Flu tests from R-Biopharm also detect new virus variants25.11.2022 11:23:27 CET | Press release

Darmstadt, November 25, 2022: The flu season has begun and different virus variants are also circulating in Germany. With the flu tests from biotechnology company R-Biopharm, patients quickly have certainty: Its RIDA®GENE Flu assays also reliably detect the two novel variants. The company made the announcement with regard to influenza A H1N1pdm09, which is circulating primarily in the United Kingdom, and the H3N2 subtype, which was rampant in Denmark in the spring and is currently dominating influenza activity in Germany. "Mutations in the target gene (MP gene) can affect the diagnostic performance of influenza screening assays, producing false-negative test results," explains Dr. Andreas Simons, Head of Product Management at R-Biopharm. " Alignments of the detection systems we used with the described sequences of the two novel virus variants showed no mismatches. Their reliable detection is not affected by the described mutations." This means laboratories can continue to reliably conf

Grunenthal Group: Janneke van der Kamp joins Grünenthal as new Chief Commercial Officer22.11.2022 11:27:30 CET | Press release

(Aachen, Germany): Grünenthal today announced that Janneke van der Kamp will join Grünenthal as the new Chief Commercial Officer (CCO), effective 1 March 2023. Janneke van der Kamp joins Grünenthal from Novartis, where she most recently served as Head of Pharma Region Europe. The Dutch native brings broad experience in the pharmaceutical industry from several roles including General Manager, Global Neurosciences Franchise Head and Global Head of Product and Portfolio Strategy for the entire Novartis Pharma portfolio. She worked closely with Research & Development and the Licensing & Acquisitions teams to strengthen the company’s pipeline. Janneke van der Kamp has vast expertise in launching and growing key brands across several disease areas. She is a studied chemist and holds an MBA from INSEAD. As CCO of Grünenthal, Janneke van der Kamp will be responsible for the entire Global Commercial Organisation and serve as a member of the Corporate Executive Board. Her focus will be to contin

Reboots extends its partnership with Spanish national football player Pedri González15.11.2022 09:43:36 CET | Press release

(Schluechtern, Germany) – Reboots, the leading European supplier of recovery boots and pants, announces the extension of its partnership with the exceptional football talent Pedri González (19). Together on the road to success The past year has been particularly successful for Pedri. Already at the beginning of the partnership with Reboots, the professional football player reached a new milestone in his sporting career by winning the Golden Boy Award 2021 in addition to the Kopa Trophy and numerous outstanding achievements with FC Barcelona. "Reboots is keen to enter into long- term partnerships. That's why we are delighted to continue to support Pedri's career and assist his regeneration," says Tom Keller, CEO of Reboots. The partners are planning more joint projects in the coming year to raise awareness about the importance of regeneration at a young age. The past year was also a special one for Reboots. The company launched the world's smallest recovery boots device: the smart Reboo

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom